Buscar

01/10/2024 Contextual-compassion training for borderline personality disorder with long lasting symptoms: A randomized clinical trial
Casellas-Pujol, E, Soler, J, Schmidt, C, Soria-Madrid, A, Elices, M, Pascual, JC. Contextual-compassion training for borderline personality disorder with long lasting symptoms: A randomized clinical trial. Journal of Contextual Behavioral Science. 2024; 34DOI:10.1016/j.jcbs.2024.100846. PMID:. IF:3.000(Q1/3D).
01/10/2024 A pilot, randomized, three-arm, dose-finding, placebo-controlled, parallel study to evaluate the use of nabiximols (THC plus CBD, Sativex®) for cannabis detoxification treatment versus treatment as usual
Bonifacio, DM, Rodríguez, MP, Perelló, PM, Hurtado, JC, Albet, JT, Tutusaus, XR, Arbós, RMA. A pilot, randomized, three-arm, dose-finding, placebo-controlled, parallel study to evaluate the use of nabiximols (THC plus CBD, Sativex®) for cannabis detoxification treatment versus treatment as usual. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY. 2024; 135DOI:. PMID:. IF:3.300(Q2/4D).
02/09/2024 How does mindfulness skills training work to improve emotion dysregulation in borderline personality disorder?
Schmidt, C, Soler, J, Vega, D, Nicolaou, S, Arias, L, Pascual, JC. How does mindfulness skills training work to improve emotion dysregulation in borderline personality disorder?. Borderline Personality Disorder and Emotion Dysregulation. 2024; 11(1)DOI:10.1186/s40479-024-00265-0. PMID:39218933. IF:2.700(Q2/4D).
01/09/2024 Cognitive insight in first-episode psychosis: Exploring the complex relationship between executive functions and social cognition
López-Carrilero, R, Lo Monaco, M, Frígola-Capell, E, Ferrer-Quintero, M, Díaz-Cutraro, L, Verdaguer-Rodríguez, M, García-Mieres, H, Vila-Badia, R, Punsoda-Puche, P, Birulés, I, Peláez, T, Pousa, E, Grasa, E, Barajas, A, Ruiz-Delgado, I, Barrigón, ML, Gonzalez-Higueras, F, Lorente-Rovira, E, Gutiérrez-Zotes, A, Cid, J, Legido, T, Ayesa-Arriola, R, Moritz, S, Ochoa, S. Cognitive insight in first-episode psychosis: Exploring the complex relationship between executive functions and social cognition. SPANISH JOURNAL OF PSYCHIATRY AND MENTAL HEALTH. 2024; 17(3)DOI:10.1016/j.sjpmh.2024.01.002. PMID:38219901. IF:2.800(Q2/4D).
01/09/2024 Is it possible to predict hospitalisation during intensive home treatment? A retrospective cohort study
Martín-Blanco, A, González-Fernández, A, Vieira, S, Farré, A, Isern, C, Avila-Parcet, A, Gausachs, E, Patrizi, B, Cardoner, N, Portella, MJ. Is it possible to predict hospitalisation during intensive home treatment? A retrospective cohort study. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE. 2024; 28(3-4)DOI:10.1080/13651501.2025.2461798. PMID:39954709. IF:2.700(Q2/4D).
01/08/2024 Outcomes of Bariatric Surgery in Patients with Schizophrenia
Miñambres, I, Rubio-Herrera, MA, Nicolau, J, Milad, C, Morales, MJ, Bueno, M, Calañas, A, Carceller-Sindreu, M, de Hollanda, A. Outcomes of Bariatric Surgery in Patients with Schizophrenia. Nutrients. 2024; 16(15)DOI:10.3390/nu16152487. PMID:39125367. IF:5.000(Q1/2D).
01/08/2024 Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group
Hilbert, K, Boeken, OJ, Langhammer, T, Groenewold, NA, Bas-Hoogendam, JM, Aghajani, M, Zugman, A, Åhs, F, Arolt, V, Beesdo-Baum, K, Björkstrand, J, Blackford, JU, Blanco-Hinojo, L, Böhnlein, J, Bülow, R, Cano, M, Cardoner, N, Caseras, X, Dannlowski, U, Domschke, K, Fehm, L, Feola, B, Fredrikson, M, Goossens, L, Grabe, HJ, Grotegerd, D, Gur, RE, Hamm, AO, Harrewijn, A, Heinig, I, Herrmann, MJ, Hofmann, D, Jackowski, AP, Jansen, A, Kaczkurkin, AN, Kindt, M, Kingsley, EN, Kircher, T, Klahn, AL, Koelkebeck, K, Krug, A, Kugel, H, Larsen, B, Leehr, EJ, Leonhardt, L, Lotze, M, Margraf, J, Michalowski, J, Muehlhan, M, Nenadic, I, Pan, PM, Pauli, P, Peñate, W, Pittig, A, Plag, J, Pujol, J, Richter, J, Rivero, FL, Salum, GA, Satterthwaite, TD, Schäfer, A, Schäfer, J, Schienle, A, Schneider, S, Schrammen, E, Schruers, K, Schulz, SM, Seidl, E, Stark, RM, Stein, F, Straube, B, Straube, T, Ströhle, A, Suchan, B, Thomopoulos, SI, Ventura-Bort, C, Visser, R, Völzke, H, Wabnegger, A, Wannemüller, A, Wendt, J, Wiemer, J, Wittchen, HU, Wittfeld, K, Wright, B, Yang, Y, Zilverstand, A, Zwanzger, P, Veltman, DJ, Winkler, AM, Pine, DS, Jahanshad, N, Thompson, PM, Stein, DJ, Van der Wee, NJ, Lueken, U. Cortical and Subcortical Brain Alterations in Specific Phobia and Its Animal and Blood-Injection-Injury Subtypes: A Mega-Analysis From the ENIGMA Anxiety Working Group. AMERICAN JOURNAL OF PSYCHIATRY. 2024; 181(8)DOI:10.1176/appi.ajp.20230032. PMID:38859702. IF:14.700(Q1/1D).
01/05/2024 Non-fatal suicide behaviours across phases in the COVID-19 pandemic: a population-based study in a Catalan cohort
Serrano-Gimeno, V, Diestre, A, Agustin-Alcain, M, Portella, MJ, de Diego-Adelino, J, Tiana, T, Cheddi, N, Distefano, A, Dominguez, G, Arias, M, Cardoner, V, Puigdemont, D, Perez, V, Cardoner, N. Non-fatal suicide behaviours across phases in the COVID-19 pandemic: a population-based study in a Catalan cohort. LANCET PSYCHIATRY. 2024; 11(5)DOI:10.1016/S2215-0366(24)00065-8. PMID:38631785. IF:24.800(Q1/1D).
01/04/2024 Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression
Young, AH, Baune, BT, Cardoner, N, Frey, R, Ito, T, Kambarov, Y, Lacerda, A, Rive, B, von Holt, C, Oliveira-Maia, AJ. Esketamine nasal spray shows greater improvement in health-related quality of life over 32 weeks versus quetiapine extended release in patients with treatment resistant depression. EUROPEAN PSYCHIATRY. 2024; 67DOI:10.1192/j.eurpsy.2024.749. PMID:. IF:6.700(Q1/1D).
01/04/2022 Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat
Querol-Vilaseca, M, Sirisi, S, Molina-Porcel, L, Molina, B, Pegueroles, J, Ferrer-Raventos, P, Nunez-Llaves, R, Dols-Icardo, O, Balasa, M, Iulita, MF, Blesa, R, Belbin, O, Clarimon, J, Fortea, J, Gelpi, E, Sanchez-Valle, R, Lleo, A. Neuropathology of a patient with Alzheimer disease treated with low doses of verubecestat. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2022; 48(3)DOI:10.1111/nan.12781. PMID:34825396. IF:5.000(Q1/2D).
01/03/2022 Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis
Hostettler, IC, Wilson, D, Fiebelkorn, CA, Aum, D, Ameriso, SF, Eberbach, F, Beitzke, M, Kleinig, T, Phan, T, Marchina, S, Schneckenburger, R, Carmona-Iragui, M, Charidimou, A, Mourand, I, Parreira, S, Ambler, G, Jager, HR, Singhal, S, Ly, J, Ma, H, Touze, E, Geraldes, R, Fonseca, AC, Melo, T, Labauge, P, Lefevre, PH, Viswanathan, A, Greenberg, SM, Fortea, J, Apoil, M, Boulanger, M, Viader, F, Kumar, S, Srikanth, V, Khurram, A, Fazekas, F, Bruno, V, Zipfel, GJ, Refai, D, Rabinstein, A, Graff-Radford, J, Werring, DJ. Risk of intracranial haemorrhage and ischaemic stroke after convexity subarachnoid haemorrhage in cerebral amyloid angiopathy: international individual patient data pooled analysis. JOURNAL OF NEUROLOGY. 2022; 269(3)DOI:10.1007/s00415-021-10706-3. PMID:34272978. IF:6.000(Q1/2D).
27/01/2022 Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Gobom, J, Parnetti, L, Rosa-Neto, P, Vyhnalek, M, Gauthier, S, Cataldi, S, Lerch, O, Laczo, J, Cechova, K, Clarin, M, Benet, AI, Pascoal, TA, Rahmouni, N, Vandijck, M, Huyck, E, Le Bastard, N, Stevenson, J, Chamoun, M, Alcolea, D, Lleo, A, Andreasson, U, Verbeek, MM, Bellomo, G, Rinaldi, R, Ashton, N, Zetterberg, H, Sheardova, K, Hort, J, Blennow, K. Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2022; 60(2)DOI:10.1515/cclm-2021-0651. PMID:34773730. IF:6.800(Q1/2D).
01/01/2022 Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum
Baque, L, Machuca, MJ, Santos-Santos, MA. Preliminary study of the temporal variables of continuous speech in patients with neurodegenerative syndromes of the frontotemporal lobar degeneration spectrum. REVISTA DE NEUROLOGIA. 2022; 74(2)DOI:10.33588/rn.7402.2021197. PMID:35014018. IF:1.200(Q4/10D).
10/12/2021 Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia
Zhu, N, Santos-Santos, M, Illan-Gala, I, Montal, V, Estelles, T, Barroeta, I, Altuna, M, Arranz, J, Munoz, L, Belbin, O, Sala, I, Sanchez-Saudinos, MB, Subirana, A, Videla, L, Pegueroles, J, Blesa, R, Clarimon, J, Carmona-Iragui, M, Fortea, J, Lleo, A, Alcolea, D. Plasma glial fibrillary acidic protein and neurofilament light chain for the diagnostic and prognostic evaluation of frontotemporal dementia. Translational Neurodegeneration. 2021; 10(1)DOI:10.1186/s40035-021-00275-w. PMID:34893073. IF:9.883(Q1/1D).
01/12/2021 Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults
Rodriguez-Vieitez, E, Montal, V, Sepulcre, J, Lois, C, Hanseeuw, B, Vilaplana, E, Schultz, AP, Properzi, MJ, Scott, MR, Amariglio, R, Papp, KV, Marshall, GA, Fortea, J, Johnson, KA, Sperling, RA, Vannini, P. Association of cortical microstructure with amyloid-beta and tau: impact on cognitive decline, neurodegeneration, and clinical progression in older adults. MOLECULAR PSYCHIATRY. 2021; 26(12)DOI:10.1038/s41380-021-01290-z. PMID:34588623. IF:13.437(Q1/1D).
01/12/2021 Specific Susceptibility to COVID-19 in Adults with Down Syndrome (Mar, 10.1007/s12017-021-08651-5, 2021)
Illouz, T, Biragyn, A, Frenkel-Morgenstern, M, Weissberg, O, Gorohovski, A, Merzon, E, Green, I, Iulita, F, Flores-Aguilar, L, Dierssen, M, De Toma, I, Lifshitz, H, Antonarakis, SE, Yu, EE, Herault, Y, Potier, MC, Botte, A, Roper, R, Sredni, B, Sarid, R, London, J, Mobley, W, Strydom, A, Okun, E. Specific Susceptibility to COVID-19 in Adults with Down Syndrome (Mar, 10.1007/s12017-021-08651-5, 2021). NEUROMOLECULAR MEDICINE. 2021; 23(4)DOI:10.1007/s12017-021-08657-z. PMID:33948879. IF:4.103(Q2/5D).
01/12/2021 Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy
Gelpi, E, Aldecoa, I, Lopez-Villegas, D, Abellan-Vidal, MT, Mercadel-Fananas, P, Fortea, J, Ribosa, R, Morenas, E, Gomez-Anson, B, Molina-Porcel, L, Ximelis, T, Borrego, S, Antonell, A, Rovelet-Lecrux, A, Klotz, S, Andres-Benito, P, Sanchez-Valle, R, Ferrer, I. Atypical astroglial pTDP-43 pathology in astroglial predominant tauopathy. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY. 2021; 47(7)DOI:10.1111/nan.12707. PMID:33730418. IF:6.250(Q1/2D).
01/12/2021 Specific Susceptibility to COVID-19 in Adults with Down Syndrome
Illouz, T, Biragyn, A, Frenkel-Morgenstern, M, Weissberg, O, Gorohovski, A, Merzon, E, Green, I, Iulita, F, Flores-Aguilar, L, Sotos, MDD, De Toma, I, Lifshitz, H, Antonarakis, SE, Yu, E, Herault, Y, Potier, MC, Botte, A, Roper, R, Sredni, B, Sarid, R, London, J, Mobley, W, Strydom, A, Okun, E. Specific Susceptibility to COVID-19 in Adults with Down Syndrome. NEUROMOLECULAR MEDICINE. 2021; 23(4)DOI:10.1007/s12017-021-08651-5. PMID:33660221. IF:4.103(Q2/5D).
16/11/2021 Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy (vol 13, 160, 2021)
De Kort, AM, Kuiperij, HB, Alcolea, D, Kersten, I, Versleijen, AAM, Greenberg, SM, Stoops, E, Schreuder, FHBM, Klijn, CJM, Lleo, A, Claassen, JAHR, Verbeek, MM. Cerebrospinal fluid levels of the neurotrophic factor neuroleukin are increased in early Alzheimer's disease, but not in cerebral amyloid angiopathy (vol 13, 160, 2021). Alzheimers Research & Therapy. 2021; 13(1)DOI:10.1186/s13195-021-00929-x. PMID:34784952. IF:8.831(Q1/1D).
01/11/2021 Alternative platelet activation pathways and their role in neurodegenerative diseases
Ferrer-Raventos, P, Beyer, K. Alternative platelet activation pathways and their role in neurodegenerative diseases. NEUROBIOLOGY OF DISEASE. 2021; 159DOI:10.1016/j.nbd.2021.105512. PMID:34537329. IF:7.046(Q1/2D).